Cambridge-based deeptech startup Auryx has closed a $2 million pre-seed round led by Celero Ventures, with participation from PurposeTech, EWOR, Cambridge Enterprise Ventures, and Vento, as Vestbee was informed.
- Founded in 2024 by Erika Bondareva, Kayla-Jade Butkow, and Cecilia Mascolo, Auryx develops software that uses microphones in consumer devices, such as earbuds, to monitor physiological signals.
- The system analyses acoustic data generated by the body, such as heartbeats, breathing, and blood flow, using machine learning models trained on research from the University of Cambridge.
- By processing these signals, it can estimate metrics including heart rate and respiratory rate without relying on optical sensors or additional hardware, operating passively through devices users already wear.
Details of the deal
- With the fresh capital, the firm plans to integrate its audio-based health monitoring software into consumer devices starting with earbuds, further develop its machine learning models, expand partnerships with hardware manufacturers, and grow its team to support commercial deployment.
"The founders are among the most qualified people in the world working on health sensing, with a proprietary knowledge base and more than a five-year head start over anyone else attempting this. We believe they are uniquely positioned to build breakthrough software that will transform how health data is collected and evaluated in everyday life and to establish themselves as the global category leader," explains Zdenek Fred Fous, General Partner at PurposeTech.
